The substantial beat on both earnings per share (EPS) and sales estimates for Q1 2024, coupled with a significant year-over-year sales growth, is likely to positively impact investor sentiment and the stock price of Emergent BioSolutions in the short term. The company's performance far exceeded analyst expectations, which typically leads to increased investor confidence and could result in a rise in stock price as the market reacts to the positive news.